Conformational effects of the substitution of Arg for Gly 13 in the ras oncogene-encoded P21 protein
- PMID: 3076451
- DOI: 10.1007/BF01024884
Conformational effects of the substitution of Arg for Gly 13 in the ras oncogene-encoded P21 protein
Abstract
The effect of the substitution of Arg for Gly 13 on the structure of the transforming region decapeptide (Leu 6-Gly 15) of the ras oncogene encoded P21 protein has been investigated using conformational energy analysis. A human malignancy has been identified that contains a ras gene with a single mutation in the thirteenth codon such that the encoded protein would have Arg substituted for Gly at this position, and transfection of cells in culture with this gene results in malignant transformation. Conformational analysis demonstrates that the Arg 13 decapeptide adopts a conformation identical to that for other peptides with substitutions at position 13 (Asp 13, Val 13) from transforming proteins that is distinctively different from that for peptides (Gly 13, Ser 13) from normal, nontransforming proteins. This is found to be an indirect effect resulting from changes in the conformation of Gly 12 produced by substitutions at position 13. These results are consistent with recent analysis of crystallographic data of proteins on conformational preferences for glycine in tripeptide sequences.
Similar articles
-
Conformational effects of amino acid substitutions at positions 10, 12, and 13 in the P21 protein.J Protein Chem. 1989 Feb;8(1):79-86. doi: 10.1007/BF01025080. J Protein Chem. 1989. PMID: 2669815
-
Comparison of the low energy conformations of an oncogenic and a non-oncogenic p21 protein, neither of which binds GTP or GDP.J Protein Chem. 1994 Feb;13(2):237-51. doi: 10.1007/BF01891982. J Protein Chem. 1994. PMID: 8060496
-
Comparison of the computed structures for the phosphate-binding loop of the p21 protein containing the oncogenic site Gly 12 with the X-ray crystallographic structures for this region in the p21 protein and EFtu. A model for the structure of the p21 protein in its oncogenic form.J Biomol Struct Dyn. 1989 Apr;6(5):859-75. doi: 10.1080/07391102.1989.10506518. J Biomol Struct Dyn. 1989. PMID: 2686707
-
Pathways for activation of the ras-oncogene-encoded p21 protein.Ann Clin Lab Sci. 1992 Sep-Oct;22(5):323-42. Ann Clin Lab Sci. 1992. PMID: 1524403 Review.
-
Three-dimensional structure and properties of wild-type and mutant H-ras-encoded p21.Ciba Found Symp. 1993;176:6-21; discussion 21-7. doi: 10.1002/9780470514450.ch2. Ciba Found Symp. 1993. PMID: 8299426 Review.
Cited by
-
Conformational effects of amino acid substitutions at positions 10, 12, and 13 in the P21 protein.J Protein Chem. 1989 Feb;8(1):79-86. doi: 10.1007/BF01025080. J Protein Chem. 1989. PMID: 2669815